Last Updated: 9 January 2025

Innovaccer, a leading healthcare AI company, recently announced a $275M Series F funding round. This round blends primary and secondary funding, signaling a high level of confidence from investors in Innovaccer’s approach to modernizing healthcare using data and AI.
Although Innovaccer hasn’t shared its latest valuation publicly, the funding includes significant participation from B Capital Group, Banner Health, Danaher Ventures LLC, Generation Investment Management, Kaiser Permanente, and M12.
With these prominent organizations on board, it’s clear the market recognizes Innovaccer’s potential to reshape healthcare through more collaborative and data-driven methods.
Innovaccer offers software solutions that help healthcare providers transition to value-based care, improve patient experiences, and lessen paperwork. It has earned Best-in-KLAS recognition in several categories, including Data and Analytics, Population Health Management, and CRM. Such honors spotlight Innovaccer’s focus on delivering innovative, high-quality technology across the healthcare sector.
"Innovaccer is dedicated to transforming healthcare through data-driven insights and cutting-edge AI technology. We are grateful for the confidence our investors have in our vision and capabilities. This funding will enable us to push the boundaries of what’s possible in healthcare AI. Our goal is to make healthcare more proactive, predictive, and personalized."
Abhinav Shashank, Co-founder and CEO of Innovaccer
These initiatives suggest that Innovaccer is not just offering off-the-shelf tools, but rather building a platform designed to unify and simplify complex healthcare systems, thereby benefiting clinicians, patients, and administrators alike.
With this infusion of capital, Innovaccer plans to deepen its work with existing customers, expand AI and cloud capabilities, and develop a robust developer ecosystem on its platform.
Specifically, it intends to introduce multiple copilots and agents focused on essential healthcare tasks, such as utilization management, prior authorization, clinical decision support, clinical documentation, care management, and contact center operations.
Looking ahead, Innovaccer is aiming to accelerate efforts that have already helped it serve 6 of the top 10 health systems in the United States.
It also continues to partner with public sector entities, like San Mateo County and Alameda County. By growing its network and offerings, Innovaccer intends to preserve its 50% year-over-year revenue growth and keep providing AI solutions that simplify the intricate world of healthcare data.
Innovaccer focuses on activating the flow of healthcare data so providers, payers, and government organizations can deliver more intelligent and connected patient experiences. Its Healthcare Intelligence Cloud turns fragmented data into clear, actionable insights that improve care quality and operations.
The company was founded in 2014 by a team that includes CEO Abhinav Shashank. Since then, Innovaccer has become known for helping major healthcare organizations—such as CommonSpirit Health, Kaiser Permanente, and Banner Health—modernize their systems. A board of seasoned healthcare and technology experts guides the company’s development.
Innovaccer stands out by focusing on end-to-end data solutions that integrate seamlessly with existing healthcare infrastructures. This approach aims to enhance the human side of healthcare through proactive, predictive care.
The company’s emphasis on AI-driven insights and usability helps medical professionals spend more time with patients and less time on cumbersome administrative tasks.
Innovaccer has now raised a total of $675M from various venture capital firms and strategic investors. Among the key participants in this round and prior rounds are:
“Innovaccer has a vision for how data and AI can power the future of healthcare that aligns with the opportunities for AI we see at Danaher. We see this investment as an opportunity to partner with Innovaccer and other industry leaders to tackle some of healthcare’s biggest challenges. We believe providing clinicians with the data and analytics to drive meaningful clinical insights, more quickly, at the point of need, we can accelerate the transition to more effective, more personalized care.”
Julie Sawyer Montgomery, Executive Vice President, at Danaher Corporation